Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REJOICE: TX-004HR for Vulvar and Vaginal Atrophy
NCT02253173Phase 3Completed
- Sponsor
- TherapeuticsMD
- Start
- Sep 2014
- Primary completion
- Oct 2015
- Modality
- Hormone, Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of estradiol in vulvovaginal atrophy (VVA), dyspareunia, sponsored by TherapeuticsMD. Started Sep 2014; status: completed.
02
Drugs
estradiol
03
Conditions
vulvovaginal atrophy (VVA)dyspareunia
Beyond the preview
Go deeper on NCT02253173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253173.